Introduction
Coronary heart disease is an important cause of mortality, morbidity and quality of life impairment, as well as a leading source of resource utilization [1] . Occlusion of coronary arteries reduces the blood flow to the heart impairing its function and determining the occurrence of angina and/or myocardial infarction. Techniques which can restore blood flow to the heart, i.e. revascularization procedures such as CABG or PTCA, can relieve suffering and add years to patients' lives. Although CABG and PTCA are both invasive procedures, they complement, rather than replace, each other. PTCA's main advantage is that it can be repeated, being moderately traumatic, although its high early restenosis rate reduces its effectiveness in the long-term. CABG's main advantages are its good long-term results, while its main disadvantage is the increased risk of severe complications and difficulties if a re-operation is required [1] . Concerns about quality of care and increasing health care costs have led to efforts to explore and identify inappropriate care. Methods aimed at detecting and quantifying appropriateness have traditionally been concerned with 'over-use' as the main quality problem. Less commonly, attention has been paid to 'under-use' due to either lack of prompt adoption of an effective procedure in clinical practice, or shortage of resources or lack of professional competence.
For the present investigation we used data from a study originally planned to assess the appropriate/ inappropriate use of CABG/PTCA procedures in Northern Italy. Details of the study have been reported elsewhere [2] . The main finding of the study was that many patients, who should have been referred for a re-vascularization procedure, were recommended medical therapy. We therefore designed a follow-up study to see whether the latter had, in the subsequent 9 months, undergone CABG or PTCA, and whether those receiving either procedure had a better outcome that those who did not. Our study was, in other words, designed to answer the following pragmatic question: 'do patients, with clinical characteristics that make them an appropriate candidate for a revascularization procedure experience higher mortality if they do not get the procedure'? Our results thus represent both an assessment of the impact of under-use of effective procedures in patients who can benefit from them and also explore the validity of the RAND appropriateness method in predicting patients' outcome.
Patients and methods

The RAND appropriateness method
In the original study that prompted this outcome survey we used the 'RAND Corporation Appropriateness Method' (thereafter referred to as the 'RAND method') to establish criteria for the appropriateness of coronary revascularization. The method starts with a review of the literature that prompts the identification of critical factors (i.e. patients' personal and clinical characteristics) that should be taken into account when deciding whether the procedure is, or is not, appropriate. Once these critical factors are identified, all the possible combinations of these characteristics (called 'indications') are created to represent hypothetical patients. A multidisciplinary expert panel [3] [4] [5] then rated the appropriateness of a given procedure for each indication. To establish the appropriateness criteria, panelists review indications and rate them from 1 (indicating that it would be highly inappropriate to provide the procedure to a patient fitting the indication) to 9 (meaning that it would be highly appropriate to provide the procedure to such a patient). This process is carried out twice, with each panelist working alone (first rating) and then with panelists meeting all together and re-rating each indication following group discussion. Panelists rate each indication twice: (a) the appropriateness of CABG surgery vs medical therapy; (b) the appropriateness of PTCA vs medical therapy. Once these ratings are defined they are applied to populations of real patients and appropriateness rates are calculated [1] . The RAND method has been used to identify both over-use [3] [4] [5] and more recently, under-use [6] of medical/surgical procedures. However, such a method has been criticized because it 'provides a refined way of recording conventional wisdom about efficacy of medical therapies' [7] and because there is insufficient evidence that this tool is valid, worth the investment, and ready for widescale implementation [8] .
The initial appropriateness study
This study represents the extension of a descriptive cohort study aimed at assessing the appropriateness of cardiac revascularization in Lombardy, a region in Northern Italy with 9 million inhabitants. Results in terms of the distribution of appropriate, uncertain and inappropriate indications have already been reported elsewhere [2] . In the original appropriateness study [2] , a multispecialty expert panel convened by the Italian Association of Hospital Cardiologists (ANMCO) rated the appropriateness of 898 'theoretical indications' for CABG, and PTCA using the RAND method [9] . Once set according to the rules described above, these ratings were used to judge the indications assigned to a cohort of 1747 patients seen at 16 centres in Northern Italy (February-May 1995) after a coronary angiogram.
Indications for CABG were judged appropriate in 565 (80%) patients, uncertain in 111 (16%) and inappropriate in 25 (4%). Corresponding values for PTCA were 40% (n=262), 46% (n=300) and 14% (n=90). Among the 394 to whom medical therapy was recommended after the angiogram, the indication was appropriate in only 14% (n=57) and uncertain for 30% (n=117), while for the remaining 220, the indications were inappropriate; this suggested a substantial under-use, as 56% patients in this category should have received a revascularization procedure (either CABG or PTCA). Examples of the clinical characteristics of these patients are reported in Table 1 where the clinical characteristics of the 10 most frequent 'hypothetical' patients, rated as appropriate candidates for a revascularization procedure, are reported. This worrying evidence of (at least potential) under-use prompted the decision to follow-up all patients who, according to the panel's judgement, should have been operated on in order to ascertain whether -considering the good evidence of effectiveness of CABG and PTCA [10, 11] -failure to use them when indicated (i.e. under-use) would have had any consequence on survival.
The outcome survey
In order to carry out this outcome evaluation we used data from the initial appropriateness study [2] obtained from: (a) revascularization laboratories; (b) hospital patients' medical records; (c) death certificates from administrative files obtained from the town of patients' residence. The information was collected using precoded standardized forms. Vital status was ascertained as of June 1998. The minimum follow-up was 9 months. Clinical information on symptoms, current medications and performance of re-vascularization procedures was collected and stored, together with information on vital status at the last visit.
Data analysis
Relative risk and hazard ratio were used to assess the impact of performing or not performing a revascularization procedure within 9 months from the angiogram, given that the expert panel indicated it. Covariates have been operationally defined as follows: patients' age at the time of the angiogram (<46, 46-65, >65); gender (M,F); surgical risk (high, low); presence of co-existent diseases at the time of the angiogram (yes, no); presence of acute myocardial infarction on the angiogram (yes, no); heart failure severity classification according to the New York Heart Association classification (NYHA) (0-I, II-IV) [12] ; chronic stable angina class at the time of the angiogram according to Canadian Cardiovascular Society classification (0-I, II-IV) [12] ; number of total coronary artery lesions detected from the angiogram (one-vessel disease vs two-or more).
In order to perform the data analysis three SAS macro programs, a database, and an SAS program were developed [12, 13] . Univariate and freq SAS procedures were used in order to obtain the means, standard deviations, quintile ranks, ranges, and frequency tables for the variables under investigation, and also to detect any outliers within the data set. Two by two contingency tables were constructed and crude relative risk, and adjusted relative risk for the procedure performancemortality associations calculated. 95% confidence intervals, chi-square values, and P-values based on a Mantel-Haenszel technique were calculated for each crude relative risk or adjusted relative risk.
The Breslow-Day test for heterogeneity was performed to detect any possible interaction among independent variables in the stratified mortality-procedure relationship using a statistically significant P-value <0·05. Before constructing the final multivariate model, a test for collinearity was carried out using either the correlation procedure in SAS or an SAS macro for collinearity diagnostics [15] [16] [17] . A multiple logistic regression procedure was thus performed to test the multivariate model constructed with and without the interaction terms using the chi-square statistic of the likelihood ratio tests with a significant P-value <0·05.
Finally, the stratified log-rank test and Cox proportional hazards models were used to compare differences between those receiving or not CABG/PTCA, simultaneously adjusting for all other risk factors. Survival curves were generated using the Kaplan-Meier method, again testing for inter-action.
Results
Out of the 1747 patients enrolled in the original appropriateness study, 1258 (72%) had an indication for a revascularization procedure, according to the expert panel. Of them 1213 (96%) had no missing data and could be included in the outcome survey. Table 2 reports the distribution of patients' age, gender, clinical characteristics, and revascularization performance according to their vital status (dead, alive) at the end of follow-up.
Patients' mean age was 62 (SD 9·5) (range 31-94). Five percent of the patients (n=56) were 45 or younger, 55% (n=663) in the 46-65 age group, and 40% (n=494) older than 65 years. Eighty-five patients (7%) were at high and 1128 (93%) at low surgical risk. Thirty-one percent (n=372) of patients had no co-existent disease at the time of the index angiogram, while 69% (n=841) had at least one co-morbid condition (mean number of co-existing diseases was one, ranging between 0 and 4). As shown in Table 2 , 512 (42%) patients had not suffered a previous myocardial infarction at the time of the angiogram. According to the New York Heart Association classification for heart failure severity, 94% (n=1143) of patients had been classified in a range between 0 and I level of severity, 6% (n=70) had a level of severity dII. Fifty-seven percent of patients (n=691) 
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had a level of chronic angina cI (Canadian Classification) at angiogram, thus 522 (43%) subjects had angina classified as II-IV, according to the Canadian Classification. Patients' mean coronary lesions were 3·3 lesions (SD 1·65) (range 1-8). Three-hundred and fifty patients (29%) did not undergo a revascularization procedure, 863 (71%) received either CABG or PTCA within 9 months from the angiogram. Overall, during the follow-up period, 79/1213 (6·5%) patients died, 42 among the 863 who received CABG or PTCA and 37 among the 350 not receiving a re-vascularization procedure. Mortality was significantly lower among those who received the recommended procedure (42/863=4·8%) compared to those who did not (37/350=10·6%). Table 3 reports the unadjusted relative risk of mortality by revascularization status. The risk of those receiving either CABG or PTCA was almost halved compared to those who did not (relative risk=0·46, 95% confidence intervals: 0·30-0·70). Table 3 also lists the univariate unadjusted risks of death associated with each clinical factor. In the univariate analysis, relative risk of death was significantly increased in patients with high surgical risk (relative risk=3·37, 95% confidence intervals: 2·04-5·55). Table 4 reports the results of the stratum-specific adjusted relative risks for the association between mortality and performance of a revascularization procedure. All relative risks are statistically significant.
Results of the logistic regression model analysis are shown in Table 5 : they are remarkably similar to the unadjusted results in Table 3 . After simultaneously controlling for all covariates, performance of either CABG/PTCA and surgical risk were all independently associated to the risk of death. Specifically, those receiving a procedure within 9 months were less likely (relative risk=0·48, 95% confidence intervals: 0·30-0·77) to die compared to those not operated. Being at high surgical risk put patients at an increased risk of death (relative risk=3·7, 95% confidence intervals: 1·83-7·44). No interaction was detected (chi-square=5·991 with 2 d.f.; P-value >0·05). Furthermore, no multicollinearity was detected for this model (the condition indices' range related to the risk factors was found to be [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .
The median follow-up times of the groups of patients who did and did not receive a revascularization procedure were 36 and 11 months, respectively (interquartile ranges [IQR] 11-37 and 9·5-25·5) with 93% of patients alive with less than 3 years of observation.
The multivariate Cox analysis provides an opportunity of looking at patterns of events over time. Survival rates and their relative hazard ratios are reported in Table 6 and unadjusted and adjusted survival curves shown in Figs 1 and 2 . Performing a revascularization procedure significantly improved survival (hazard ratio=0·31; 95% confidence intervals: 0·19, 0·50). This analysis also confirmed the roles of surgical risks (hazard ratio=3·6; 95% confidence intervals: 1·91, 6·94). Again, no interaction was found.
Discussion
Our study suggests that -at least with reference to the period 1995-1996 when this patient cohort was cared for -under-use of CABG/PTCA was an important quality of care problem in Northern Italy, with measurable negative consequences on patient outcome. The best estimate obtainable from this patient population is that, when clinically appropriate, revascularization within 9 months could have reduced the odds of death by 52%, lowering mortality from 10% to approximately 4%.
Our findings thus indicate that some potentially avoidable deaths may have occurred either because patients waited too long before cardiac surgery, because an erroneous recommendation was given after the performance of an angiogram or finally, because some refused to undergo an otherwise recommended procedure. Our study does not indicate which of the above was the most important determinant of our findings, as we had no information on the decision-making process. However, data shown in Table 1 seem more consistent with the hypothesis that 'limited capacity' (i.e. waiting lists) was an important factor. Patients who did and did not receive a revascularization procedure are in fact quite similar, apart from those who were primarily operated on for valve surgery, who were more frequently 
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represented among those non-operated on (14·6%) than among those who were revascularized (3·2%). Thus, although Italy has one of the highest densities of cardiologists, our findings support the hypothesis that, at least with reference to the index period of the study, limited capacity existed in Regione Lombardia. This situation has since changed and a large number of cardiosurgical beds (mostly in the private sector) are now available. This has led in only 5 years (from 1993 to 1997) to a marked increase in the utilization rates of CABG and PTCA. Specifically, CABG increased by 102% (from 252 to 508 per million inhabitants) and PTCA by 178% (from 178 to 494 per million inhabitants) (Grilli R. et al., Regione Lombardia, Unpublished data). This would suggest that over-use as well as under-use should, from now on, be routinely monitored. What we found is particularly interesting, as it closely corresponds to what one would expect, considering the results of the Coronary Artery Bypass Graft Surgery Trialists collaboration [18] : patients randomized to receive CABG had a significantly lower 5-year mortality compared to medical therapy (odds ratio=0·61; 95% confidence intervals: 0·48 to 0·77).
We are fully aware that the observational nature of this study does not provide the best opportunity for postulating a causal relationship between performance of a cardiac procedure and a better outcome. Therefore, before accepting the validity of our findings, a few alternative explanations should be discussed.
First, cardiologists or surgeons at participating hospitals may have systematically selected better patients for invasive procedures. However, our estimate did not change even after we controlled for a wide array of individual clinical variables as well as for two different previously validated multivariable risk indexes.
Second, waiting-time bias could have affected our results if patients died while waiting for revascularization. To explore this possibility we performed a further analysis, excluding all the patients who had died within 30 days from the coronary angiogram or revascularization procedure(s). The results of this analysis showed similar results. In fact, patients who received revascularization within 9 months of angiography still had lower mortality than those who did not (adjusted odds ratio=0503; 95% confidence intervals: 0·29 to 0·88).
A third potential source of bias could be that all deaths might not have been ascertained if some patients who were presumed alive had died. However, through the review of local death certificates from administrative files obtained from the town of patients' residence, we assessed the vital status, as of June 1998, of all patients not dead at the time of the first follow-up. Our conclusion would change only if a substantial number of these patients had died and if most of them had undergone revascularization. A fourth possible explanation for the reduced mortality among patients treated with CABG/PTCA is that these patients were cared for more closely and carefully during the first few years after the angiogram. According to this hypothesis, it was not the procedure itself but rather the non-specific attention accompanying the procedure that produced the survival benefit. A future study of this type should examine in greater depth the afterangiogram process of care (including amount and type of follow-up care and use of specialists) as well as outcomes.
In considering our results it is important to bear in mind that we examined only one aspect of the validity of appropriateness criteria: the detection of potential under-use of revascularization. Using guidelines to detect unnecessary or inappropriate utilization (i.e. overuse) may or may not be similarly valid. Furthermore, these guidelines as well as other guidelines will require regular updating to reflect advances in clinical practice 
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and avoid obsolescence. A final consideration stemming from our study is that it adds some evidence of the validity of the RAND method for assessing appropriateness of coronary revascularization: patients not operated on when CABG or PTCA were clinically indicated had a worse outcome compared to those who underwent the intervention. The only other study reporting similar findings was published by Kravitz et al. [6] who found that the odds ratio for 1-year mortality for those receiving a CABG/PTCA vs those who did not undergo the procedure was 0·49 (95% confidence intervals: 0·28 to 0·86). However, it must be borne in mind that the methods used in the two studies were not completely similar. Kravitz et al. looked, in fact, at the impact of under-use only in patients where the revascularization procedure was rated 'necessary', a criterion likely to select patients with more severe heart disease. To be rated necessary a procedure needs, besides being appropriate: (a) to provide a substantial health benefit; (b) to definitely represent improper care if not performed. In our study, we did not divide patients classified as appropriate into those for whom the procedure was necessary and those for whom it was not.
In conclusion, our study documents that under-use of procedures of proven effectiveness, in patients who should receive them, adversely affects patient outcome. Monitoring quality of care should therefore not only be targeted at over-use, but also at carefully monitoring health services to ensure they are organizationally and culturally equipped to guarantee that patients receive interventions of potential benefit for their health.
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